Valerie Malyvanh Jansen - Oct 19, 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Chief Medical Officer
Signature
/s/ Joseph Ferra, Attorney-in-Fact
Stock symbol
ELEV
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
3
Date filed
10/21/2021, 06:29 PM
Next filing
Feb 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELEV Employee Stock Option (Right to Buy) Oct 19, 2021 Common Stock 159K $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on April 19, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.